ArticleJournal for immunotherapy of cancer2022

Efficacy of pembrolizumab and comprehensive CD274/PD-L1 profiles in patients previously treated with chemoradiation therapy as radical treatment in bladder cancer.

Kazuki Nishimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.